Stem Cell Ophthalmology Treatment Study (SCOTS)
Bone Marrow Derived Stem Cell Ophthalmology Treatment Study
Sponsor: MD Stem Cells
This NA trial investigates Glaucoma and Hereditary Retinal Dystrophy and is currently ongoing. MD Stem Cells leads this study, which shows 14 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Nov 2021 [monthly]
Enrolling By Invitation NA
-
Nov 2019 — Jan 2021 [monthly]
Enrolling By Invitation NA
▶ Show 9 earlier versions
-
Sep 2019 — Nov 2019 [monthly]
Enrolling By Invitation NA
-
Jul 2019 — Sep 2019 [monthly]
Enrolling By Invitation NA
-
Dec 2018 — Jul 2019 [monthly]
Enrolling By Invitation NA
-
Nov 2018 — Dec 2018 [monthly]
Enrolling By Invitation NA
-
Sep 2018 — Nov 2018 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Sep 2018 [monthly]
Enrolling By Invitation NA
-
Dec 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
-
Oct 2017 — Dec 2017 [monthly]
Enrolling By Invitation NA
Status: Recruiting → Enrolling By Invitation
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MD Stem Cells
For direct contact, visit the study record on ClinicalTrials.gov .